title: Quality of end-of-life care for patients with metastatic non-small-cell lung cancer in general wards and palliative care units in Japan.
abstract: OBJECTIVE
  Patients with lung cancer in Japan often receive aggressive care near the end of life and die in an acute care hospital. We describe the differences in end-of-life care for metastatic non-small-cell lung cancer (NSCLC) patients between general wards and a palliative care unit (PCU).
  
  
  METHODS
  A retrospective analysis was conducted using data from patients who received at least second-line chemotherapy between 2002 and 2007 in a single institute. Among 72 eligible patients, we categorised patients into two groups, those who died in general wards (n = 57) and those who died in the PCU (n = 15), and examined end-of-life care including chemotherapy, do-not-resuscitate (DNR) decision making and treatment in the last 48 h of life.
  
  
  RESULTS
  Mean number of days between the last chemotherapy and death was shorter in general wards than in the PCU (P = 0.019). Furthermore, 25% of patients in general wards received chemotherapy within the last 2 weeks of life. Rates of multiple hospitalisations in the last month of life appeared higher in general wards than in the PCU. Mean number of days between documentation of DNR and death was shorter in general wards than in the PCU (P = 0.0010). Patients in general wards received a greater volume of hydration than those in the PCU (P < 0.001).
  
  
  CONCLUSIONS
  Patients with metastatic NSCLC in general wards receive inappropriate care near the end of life. Further studies are needed to develop interventions for making decisions regarding end-of-life care.
authors.affiliation: Department of Respiratory Medicine, National Hospital Organization, Kure Medical Center, 3-1 Aoyama, Kure, Hiroshima 737-0023, Japan. knakano@kure-nh.go.jp
authors.forename: Kikuo
authors.initials: K
authors.lastname: Nakano
authors.forename: Takashi
authors.initials: T
authors.lastname: Yoshida
authors.forename: Junko
authors.initials: J
authors.lastname: Furutama
authors.forename: Shoji
authors.initials: S
authors.lastname: Sunada
mesh_terms: D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002289:Carcinoma, Non-Small-Cell Lung / Q000473:pathology / Q000628:therapy*; D003657:Decision Making; D005260:Female; D006760:Hospitalization / Q000706:statistics & numerical data; D006801:Humans; D007564:Japan; D008175:Lung Neoplasms / Q000473:pathology / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D010166:Palliative Care / Q000379:methods; D011787:Quality of Health Care; D016414:Resuscitation Orders; D012189:Retrospective Studies; D013727:Terminal Care / Q000592:standards*; D013997:Time Factors
chemical_list: D000970:Antineoplastic Agents